Literature DB >> 18564010

Typhoid vaccination: the Asian experience.

Denise DeRoeck1, R Leon Ochiai, Jin Yang, Dang Duc Anh, Vibha Alag, John D Clemens.   

Abstract

The WHO has recently issued updated recommendations for the programmatic use of new-generation typhoid vaccines in high-risk areas of countries where typhoid fever is still endemic. Countries have subsequently been instructed to discuss how these recommendations can be implemented and to develop plans for targeted typhoid vaccination. These plans can be informed by the experiences with typhoid vaccination that several Asian countries have had. This article reviews past and current typhoid vaccination programs that have taken place in Thailand (using the old whole-cell vaccine) and in China, Vietnam and India (using the new-generation injectable Vi polysaccharide vaccine). This review also describes recent typhoid Vi vaccine demonstration projects that were conducted in five Asian countries.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18564010     DOI: 10.1586/14760584.7.5.547

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  19 in total

1.  Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates.

Authors:  Changfa Cui; Rodney Carbis; So Jung An; Hyun Jang; Cecil Czerkinsky; Shousun C Szu; John D Clemens
Journal:  Clin Vaccine Immunol       Date:  2009-11-04

Review 2.  The impact of new vaccine introduction on immunization and health systems: a review of the published literature.

Authors:  Terri B Hyde; Holly Dentz; Susan A Wang; Helen E Burchett; Sandra Mounier-Jack; Carsten F Mantel
Journal:  Vaccine       Date:  2012-08-29       Impact factor: 3.641

Review 3.  Recent progress in mucosal vaccine development: potential and limitations.

Authors:  Nils Lycke
Journal:  Nat Rev Immunol       Date:  2012-07-25       Impact factor: 53.106

4.  Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi.

Authors:  F Micoli; S Rondini; I Pisoni; D Proietti; F Berti; P Costantino; R Rappuoli; S Szu; A Saul; L B Martin
Journal:  Vaccine       Date:  2010-11-27       Impact factor: 3.641

5.  The expanding spectrum of disease due to salmonella: an international perspective.

Authors:  Laila Woc-Colburn; David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

Review 6.  Global trends in typhoid and paratyphoid Fever.

Authors:  John A Crump; Eric D Mintz
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

7.  A Study on Longevity of Immune Response after Vaccination with Salmonella Typhi Vi Conjugate Vaccine (Pedatyph™) in Children.

Authors:  Balaji Chinnasami; Kanimozhi Sadasivam; Aravindhan Vivekanandhan; Prema Arunachalam; Sekar Pasupathy
Journal:  J Clin Diagn Res       Date:  2015-05-01

8.  Impact of a targeted typhoid vaccination campaign following cyclone Tomas, Republic of Fiji, 2010.

Authors:  Heather M Scobie; Eric Nilles; Mike Kama; Jacob L Kool; Eric Mintz; Kathleen A Wannemuehler; Terri B Hyde; Akanisi Dawainavesi; Sheetalpreet Singh; Samuel Korovou; Kylie Jenkins; Kashmira Date
Journal:  Am J Trop Med Hyg       Date:  2014-04-07       Impact factor: 2.345

9.  High-resolution genotyping of the endemic Salmonella Typhi population during a Vi (typhoid) vaccination trial in Kolkata.

Authors:  Kathryn E Holt; Shanta Dutta; Byomkesh Manna; Sujit K Bhattacharya; Barnali Bhaduri; Derek J Pickard; R Leon Ochiai; Mohammad Ali; John D Clemens; Gordon Dougan
Journal:  PLoS Negl Trop Dis       Date:  2012-01-31

10.  Spatiotemporal transmission and determinants of typhoid and paratyphoid fever in Hongta District, Yunnan Province, China.

Authors:  Jin-Feng Wang; Yan Wang; Jing Zhang; George Christakos; Jun-Ling Sun; Xin Liu; Lin Lu; Xiao-Qing Fu; Yu-Qiong Shi; Xue-Mei Li
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.